查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球长读定序市场：市场规模、份额、趋势：按产品、按技术、按工作流程、按应用、按用途、按最终用户、按地区 - 预测到 2029 年
市场调查报告书
商品编码
1534555

全球长读定序市场：市场规模、份额、趋势：按产品、按技术、按工作流程、按应用、按用途、按最终用户、按地区 - 预测到 2029 年

Long Read Sequencing Market Size, Share & Trends by Offerings, Workflow, Technology, Application, Usage - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 307 Pages | 订单完成后即时交付

价格

长读定序市场规模预计将从 2024 年的 7.58 亿美元增至 2029 年的 31.29 亿美元，预测期内复合年增长率为 32.8%。

调查范围
调查年份 2022-2029
基准年 2023年
预测期 2024-2029
考虑单位 金额（百万美元）
部分 按产品、按技术、按工作流程、按应用程式、按用途、按最终用户、按区域
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

长读定序市场的成长主要受到学术机构和产业参与企业之间研究合作的增加、定序成本的降低以及长读长定定序技术的不断进步等因素的推动。此外，从头基因组组装、结构变异检测、转录组学和表观遗传学等 LRS 应用正在支持市场成长。然而，对设定设备的初始成本的担忧正在影响长读定序市场的成长。

2023 年长读定序市场细分为耗材、设备和服务。消耗品是所提供产品中所占份额最大的部分。消耗品所占比例较大是因为它们在长读长定定序的样品製备、定序和资料分析部分中发挥作用。定序需求的不断增长有利于耗材领域的需求并推动市场成长。儘管如此，设备领域仍占据第二大市场占有率。

该报告研究了全球长读定序市场，包括产品、技术、工作流程、应用、使用、最终用户、地区和参与市场的公司概况的趋势。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 介绍
  • 市场动态
  • 影响客户业务的趋势/干扰
  • 监管状况
  • 价值链分析
  • 技术分析
  • 价格分析
  • 专利分析
  • 供应链分析
  • 生态系分析
  • 2024-2025年重大会议和活动
  • 波特五力分析
  • 主要相关人员和采购标准
  • 投资金筹措场景
  • 案例研究分析
  • 人工智慧对长读定序市场的影响

第六章长读定序市场（依产品分类）

  • 介绍
  • 消耗品
  • 装置
  • 服务

第七章长读定序市场（依技术）

  • 介绍
  • 奈米孔定序
  • 单分子即时定序
  • 合成长读定定序

第8章长读定序市场（依工作流程）

  • 介绍
  • 定序
  • 样品製备
  • 资料分析

第九章长读定序市场（依应用）

  • 介绍
  • 全基因组序列分析
  • 标靶定定序
  • 总体基因体学
  • 表观遗传学
  • 全EXOME定序
  • 其他的

第10章长读定序市场（依用途）

  • 介绍
  • 研究
  • 临床

第十一章长读定序市场（依最终使用者）

  • 介绍
  • 学术研究所
  • 製药和生物製药公司
  • 医院、诊所、诊断实验室
  • 其他的

第十二章长读定序市场（按地区）

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第十三章竞争格局

  • 介绍
  • 主要参与企业的策略/秘密
  • 收益分析
  • 市场占有率分析
  • 企业评估矩阵：主要参与企业，2023
  • 企业评估矩阵：Start-Ups/小型企业，2023 年
  • 公司评价及财务指标
  • 品牌/服务比较
  • 竞争场景

第十四章 公司简介

  • 主要参与企业
    • OXFORD NANOPORE TECHNOLOGIES PLC
    • PACBIO
    • ILLUMINA, INC.
    • AGILENT TECHNOLOGIES, INC.
    • THERMO FISHER SCIENTIFIC INC.
    • 10X GENOMICS, INC.
    • QIAGEN
    • BGI GROUP
    • AZENTA US, INC.
    • TAKARA BIO INC.
    • NOVOGENE CO., LTD.
    • REVVITY INC.
    • DANAHER CORPORATION
    • NEW ENGLAND BIOLABS
    • BASE CLEAR BV
  • 其他公司
    • ELEMENT BIOSCIENCES
    • GRANDOMICS
    • CD GENOMICS
    • SAGE SCIENCES, INC.
    • EDENROC SCIENCES

第十五章附录

Product Code: BT 9117

The long-read sequencing market is expected to reach USD 3,129 million in 2029 from USD 758 million in 2024, at a CAGR of 32.8% during the forecast period.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million)
SegmentsOfferings, Technology, Workflow, Applications, Usage and End Users
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

Growth in the long-read sequencing market is mainly driven by factors like increasing collaborations between academic institutions and industry players, decreased cost of sequencing, and continuous technological advancements in long-read sequencing. Moreover, the application of LRS like de novo genome assembly, structural variant detection, transcriptomics, and epigenetics is supporting the market growth. However, the initial cost concern to set up the equipment is impacting the growth of the long-read sequencing market.

"The consumables segment accounted for the largest share by offerings segment in the long-read sequencing market in 2023"

The long-read sequencing market is segmented into consumables, instruments, and services in 2023. The consumables is the segment with the largest share in offerings. The large share of consumables is due to their role in sample preparation, sequencing, and data analysis part of long-read sequencing. As the demand for sequencing increases, it supports the demand for the consumables segment, driving its growth in the market. Still, the instrument segment held the second-largest market share.

"The academic & research institutes segment accounted for the largest share by end-user segment in the long-read sequencing market in 2023"

The long-read sequencing market is segmented into academic & research institutes, pharmaceutical & biotechnologies companies, hospitals, clinics & diagnostics laboratories, and other end users. The academic & research institutes are the segment with the largest share in the end-user segment in 2023. The large share of academic & research institutes is due to the increased demand for whole genome sequencing products, and increased genomics research. However, the pharmaceutical & biotechnological companies accounted for the second largest share in the segment.

"The Asia Pacific region is growing at the highest CAGR in the long-read sequencing market from 2024 to 2029."

The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the large scale of population genomics projects, and the demand for precision medicines is supporting the growth. Further, the rising prevalence of chronic diseases is attributed to the aging population of countries such as Japan, and China. These is supporting the adoption of sequencing technologies in healthcare prognosis and treatment driving the market growth.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70% and Demand Side 30%
  • By Designation: Managers - 45% CXOs and Director-level - 30%, and Executives - 25%,
  • By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.

List of Companies Profiled in the Report:

  • Oxford Nanopore Technologies plc. (UK)
  • PacBio (US)
  • Illumina, Inc. (US)
  • Agilent Technologies, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • 10X Genomics, Inc. (US)
  • QIAGEN (Germany)
  • BGI Group (China)
  • Takara Bio Inc. (Japan)
  • Azenta US, Inc. (US)
  • Revvity, Inc. (US)
  • Danaher Corporation (US)
  • Novogene Co., Ltd. (China)
  • New England Biolabs (US)
  • BaseClear BV (Netherlands)
  • Element Biosciences (US)
  • Grandomics (China)
  • CD Genomics (US)
  • Sage Sciences, Inc. (US)
  • EdenRoc Sciences (US)

Research Coverage:

This research report categorizes the long-read sequencing market by offerings (instruments, consumables, and services), technology (single-molecule real-time sequencing, nanopore sequencing, and synthetic long-read sequencing), workflow (sample preparation, sequencing, and data analysis), application (whole genome sequencing, metagenomics, epigenetics, targeted sequencing, whole exome sequencing, and other applications), usage (research and clinical), end user (academic & research institutes, pharmaceutical & biotechnology companies, hospitals, clinics & diagnostic Labs, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the long-read sequencing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as collaborations, expansions, agreements, and recent developments associated with the long-read sequencing market. Competitive analysis of top players and upcoming startups in the long-read sequencing market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall long-read sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Technological advancements in genome sequencing, Increased prevalence of complex and rare genetic disorders, and growing demand for high-quality throughput screening), restraints (High investments to develop long read sequencing technologies, Technical Limitations of existing technology), opportunities (Rising demand for long-read sequencing in clinical genomics, and expanding applications of long-read sequencing), and challenges (challenges associated with data preservation, analysis, and validation) influencing the growth of the market.

  • Product Development/Innovation: Detailed insights on newly launched services of the long-read sequencing market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the long-read sequencing market
  • Competitive Assessment: Oxford Nanopore Technologies plc. (UK), PacBio (US), Illumina, Inc. (US), Agilent Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), 10X Genomics, Inc. (US), QIAGEN (Germany), BGI Group (China), Takara Bio Inc. (Japan), Azenta US, Inc. (US), Revvity, Inc. (US), Danaher Corporation (US), Novogene Co., Ltd. (China), New England Biolabs (US), BaseClear BV (Netherlands), Element Biosciences (US), Grandomics (China), CD Genomics (US), Sage Sciences, Inc. (US), and EdenRoc Sciences (US) among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 MARKET SIZE ESTIMATION
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 MARKET GROWTH RATE PROJECTIONS
  • 2.4 DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
  • 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 LONG-READ SEQUENCING MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY OFFERING
  • 4.3 LONG-READ SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 LONG-READ SEQUENCING MARKET SHARE, BY END USER, 2023

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Emerging technological advancements
      • 5.2.1.2 Increasing prevalence of complex and rare genetic disorders
      • 5.2.1.3 Growing demand for high-throughput sequencing
      • 5.2.1.4 Expanding applications of long-read sequencing
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High investment cost
      • 5.2.2.2 Technical limitations of existing technologies
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising adoption in clinical genomics
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Data preservation, analysis, and validation issues
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.4 REGULATORY LANDSCAPE
    • 5.4.1 REGULATORY SCENARIO
    • 5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 TECHNOLOGICAL ANALYSIS
    • 5.6.1 KEY TECHNOLOGIES
      • 5.6.1.1 Single-molecule real-time sequencing
      • 5.6.1.2 Nanopore sequencing
      • 5.6.1.3 Synthetic long-read sequencing
    • 5.6.2 COMPLEMENTARY TECHNOLOGIES
      • 5.6.2.1 Next-generation sequencing combined with artificial intelligence
      • 5.6.2.2 Single-cell sequencing
      • 5.6.2.3 Polymerase chain reaction
    • 5.6.3 ADJACENT TECHNOLOGIES
      • 5.6.3.1 Sample preparation technologies
      • 5.6.3.2 Data analysis
  • 5.7 PRICING ANALYSIS
    • 5.7.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY OFFERING
    • 5.7.2 AVERAGE SELLING PRICE OF KEY PLAYERS, BY INSTRUMENT
    • 5.7.3 AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE
    • 5.7.4 AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE
    • 5.7.5 AVERAGE SELLING PRICE, BY REGION
  • 5.8 PATENT ANALYSIS
  • 5.9 SUPPLY CHAIN ANALYSIS
  • 5.10 ECOSYSTEM ANALYSIS
  • 5.11 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.12.2 INTENSITY OF COMPETITIVE RIVALRY
    • 5.12.3 BARGAINING POWER OF SUPPLIERS
    • 5.12.4 BARGAINING POWER OF BUYERS
    • 5.12.5 THREAT OF SUBSTITUTES
    • 5.12.6 THREAT OF NEW ENTRANTS
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 KEY BUYING CRITERIA, BY END USER
  • 5.14 INVESTMENT & FUNDING SCENARIO
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 ENHANCED DETECTION OF AMYOTROPHIC LATERAL SCLEROSIS USING PACBIO SINGLE-MOLECULE, REAL-TIME SEQUENCING
    • 5.15.2 IMPROVED DIAGNOSIS OF RARE DISEASES WITH LONG-READ WHOLE-GENOME SEQUENCING
  • 5.16 IMPACT OF AI ON LONG-READ SEQUENCING MARKET

6 LONG-READ SEQUENCING MARKET, BY OFFERING

  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    • 6.2.1 LARGE NUMBER OF PLAYERS OPERATING IN CONSUMABLES SPACE TO PROPEL DEMAND
  • 6.3 INSTRUMENTS
    • 6.3.1 ADVANCEMENTS IN LONG-READ SEQUENCING TECHNOLOGY TO BOOST MARKET GROWTH
  • 6.4 SERVICES
    • 6.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO FAVOR MARKET GROWTH

7 LONG-READ SEQUENCING MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 NANOPORE SEQUENCING
    • 7.2.1 DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH
  • 7.3 SINGLE-MOLECULE REAL-TIME SEQUENCING
    • 7.3.1 HIGHLY ACCURATE LONG READS BY REPEATEDLY SEQUENCING CIRCULARIZED DNA TO DRIVE DEMAND
  • 7.4 SYNTHETIC LONG-READ SEQUENCING
    • 7.4.1 GROWING DEMAND FOR DETAILED AND COMPREHENSIVE GENOMIC DATA IN AREAS SUCH AS CLINICAL GENOMICS TO BOOST MARKET

8 LONG-READ SEQUENCING MARKET, BY WORKFLOW

  • 8.1 INTRODUCTION
  • 8.2 SEQUENCING
    • 8.2.1 DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH
  • 8.3 SAMPLE PREPARATION
    • 8.3.1 DEVELOPMENT OF ADVANCED LIBRARY PREPARATION SOLUTIONS TO BOOST MARKET
  • 8.4 DATA ANALYSIS
    • 8.4.1 DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO FAVOR MARKET GROWTH

9 LONG-READ SEQUENCING MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 WHOLE-GENOME SEQUENCING
    • 9.2.1 INCREASING USE OF WGS IN RARE DISEASE RESEARCH TO DRIVE MARKET GROWTH
  • 9.3 TARGETED SEQUENCING
    • 9.3.1 RISING DEMAND FOR LONG-READ SEQUENCING IN DISEASE DIAGNOSTICS TO SUPPORT MARKET GROWTH
  • 9.4 METAGENOMICS
    • 9.4.1 GROWING DEMAND FOR HIGH-RESOLUTION AND ACCURATE METAGENOMIC DATA TO FUEL GROWTH
  • 9.5 EPIGENETICS
    • 9.5.1 ADVANTAGES OF LRS IN EPIGENETICS STUDIES TO BOOST DEMAND
  • 9.6 WHOLE-EXOME SEQUENCING
    • 9.6.1 GROWING DEMAND FOR PRECISION GENETICS TO FAVOR MARKET GROWTH
  • 9.7 OTHER APPLICATIONS

10 LONG-READ SEQUENCING MARKET, BY USAGE

  • 10.1 INTRODUCTION
  • 10.2 RESEARCH USAGE
    • 10.2.1 RISING RESEARCH COLLABORATIONS TO BOOST MARKET GROWTH
  • 10.3 CLINICAL USAGE
    • 10.3.1 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH

11 LONG-READ SEQUENCING MARKET, BY END USER

  • 11.1 INTRODUCTION
  • 11.2 ACADEMIC & RESEARCH INSTITUTES
    • 11.2.1 ACADEMIC & RESEARCH INSTITUTES TO DOMINATE MARKET DURING FORECAST PERIOD
  • 11.3 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
    • 11.3.1 GROWING COLLABORATIONS BETWEEN LRS PLAYERS AND PHARMA-BIOTECH COMPANIES TO DRIVE GROWTH
  • 11.4 HOSPITALS, CLINICS, AND DIAGNOSTIC LABS
    • 11.4.1 RISING DEMAND FOR LONG-READ SEQUENCING IN HOSPITALS & CLINICS TO SUPPORT GROWTH
  • 11.5 OTHER END USERS

12 LONG-READ SEQUENCING MARKET, BY REGION

  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    • 12.2.1 US
      • 12.2.1.1 US to dominate North American long-read sequencing market during forecast period
    • 12.2.2 CANADA
      • 12.2.2.1 Increasing government initiatives in genomics research to aid market growth
  • 12.3 EUROPE
    • 12.3.1 GERMANY
      • 12.3.1.1 Increased funding for genomic development and application to favor market growth
    • 12.3.2 UK
      • 12.3.2.1 Favorable NHS funding and increased number of patients with rare genetic diseases to spur market growth
    • 12.3.3 FRANCE
      • 12.3.3.1 Increasing government investment in genomics and proteomics research to augment market growth
    • 12.3.4 ITALY
      • 12.3.4.1 Developed research infrastructure and increased genomics investment to fuel market growth
    • 12.3.5 SPAIN
      • 12.3.5.1 Advancements in translational and personalized medicine sector to boost market growth
    • 12.3.6 REST OF EUROPE
  • 12.4 ASIA PACIFIC
    • 12.4.1 CHINA
      • 12.4.1.1 Favorable regulatory reforms and high patient population to aid market growth
    • 12.4.2 JAPAN
      • 12.4.2.1 Technological advancements and high government investments in biotechnology to augment market growth
    • 12.4.3 INDIA
      • 12.4.3.1 Favorable government initiatives for genomics research to drive market
    • 12.4.4 SOUTH KOREA
      • 12.4.4.1 Rising government investments in cancer treatments and precision medicine to support market growth
    • 12.4.5 REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    • 12.5.1 BRAZIL
      • 12.5.1.1 Increased public and private investments in sequencing technologies to spur market growth
    • 12.5.2 MEXICO
      • 12.5.2.1 Growing prevalence of chronic disease and increasing geriatric population to support market growth
    • 12.5.3 ARGENTINA
      • 12.5.3.1 Rising healthcare investments and increasing focus on public health services to propel market growth
    • 12.5.4 REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST
    • 12.6.1 GCC COUNTRIES
      • 12.6.1.1 Saudi Arabia
        • 12.6.1.1.1 High government healthcare expenditure and technological advancements to boost market growth
      • 12.6.1.2 UAE
        • 12.6.1.2.1 Increasing R&D investment and growing healthcare infrastructure to aid market growth
      • 12.6.1.3 Rest of GCC Countries
    • 12.6.2 REST OF MIDDLE EAST
  • 12.7 AFRICA
    • 12.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET GROWTH

13 COMPETITIVE LANDSCAPE

  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 13.3 REVENUE ANALYSIS
  • 13.4 MARKET SHARE ANALYSIS
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 13.5.1 STARS
    • 13.5.2 EMERGING LEADERS
    • 13.5.3 PERVASIVE PLAYERS
    • 13.5.4 PARTICIPANTS
    • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 13.5.5.1 Company footprint
      • 13.5.5.2 Region footprint
      • 13.5.5.3 Offering footprint
      • 13.5.5.4 Application footprint
      • 13.5.5.5 Technology footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 13.7 COMPANY VALUATION & FINANCIAL METRICS
  • 13.8 BRAND/SERVICE COMPARISON
    • 13.8.1 OXFORD NANOPORE TECHNOLOGIES PLC
    • 13.8.2 PACBIO
    • 13.8.3 ILLUMINA, INC.
    • 13.8.4 AGILENT TECHNOLOGIES, INC.
    • 13.8.5 THERMO FISHER SCIENTIFIC INC.
  • 13.9 COMPETITIVE SCENARIO
    • 13.9.1 DEALS
    • 13.9.2 EXPANSIONS

14 COMPANY PROFILES

  • 14.1 KEY PLAYERS
    • 14.1.1 OXFORD NANOPORE TECHNOLOGIES PLC
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products & services offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Deals
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Right to win
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses and competitive threats
    • 14.1.2 PACBIO
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products & services offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Product & service launches
        • 14.1.2.3.2 Deals
        • 14.1.2.3.3 Expansions
        • 14.1.2.3.4 Other developments
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Right to win
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses and competitive threats
    • 14.1.3 ILLUMINA, INC.
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products & services offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Product launches
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Key strengths
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses and competitive threats
    • 14.1.4 AGILENT TECHNOLOGIES, INC.
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products & services offered
    • 14.1.5 THERMO FISHER SCIENTIFIC INC.
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products & services offered
    • 14.1.6 10X GENOMICS, INC.
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products & services offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Product launches
    • 14.1.7 QIAGEN
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products & services offered
      • 14.1.7.3 Recent developments
        • 14.1.7.3.1 Expansions
    • 14.1.8 BGI GROUP
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products & services offered
    • 14.1.9 AZENTA US, INC.
      • 14.1.9.1 Business overview
      • 14.1.9.2 Products & services offered
      • 14.1.9.3 Recent developments
        • 14.1.9.3.1 Expansions
    • 14.1.10 TAKARA BIO INC.
      • 14.1.10.1 Business overview
      • 14.1.10.2 Products & services offered
      • 14.1.10.3 Recent developments
        • 14.1.10.3.1 Deals
    • 14.1.11 NOVOGENE CO., LTD.
      • 14.1.11.1 Business overview
      • 14.1.11.2 Products & services offered
      • 14.1.11.3 Recent developments
        • 14.1.11.3.1 Other developments
    • 14.1.12 REVVITY INC.
      • 14.1.12.1 Business overview
      • 14.1.12.2 Products & services offered
    • 14.1.13 DANAHER CORPORATION
      • 14.1.13.1 Business overview
      • 14.1.13.2 Products & services offered
    • 14.1.14 NEW ENGLAND BIOLABS
      • 14.1.14.1 Business overview
      • 14.1.14.2 Products & services offered
    • 14.1.15 BASE CLEAR BV
      • 14.1.15.1 Business overview
      • 14.1.15.2 Products & services offered
  • 14.2 OTHER PLAYERS
    • 14.2.1 ELEMENT BIOSCIENCES
    • 14.2.2 GRANDOMICS
    • 14.2.3 CD GENOMICS
    • 14.2.4 SAGE SCIENCES, INC.
    • 14.2.5 EDENROC SCIENCES

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 INCLUSIONS & EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 3 LONG-READ SEQUENCING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 4 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
  • TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY INSTRUMENT, 2021-2023 (USD)
  • TABLE 11 AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE, 2021-2023 (USD)
  • TABLE 12 AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE, 2023 (USD)
  • TABLE 13 AVERAGE SELLING PRICE, BY REGION, 2021-2023 (USD)
  • TABLE 14 INNOVATIONS AND PATENT REGISTRATIONS, 2020-2024
  • TABLE 15 LONG-READ SEQUENCING MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 16 LONG-READ SEQUENCING MARKET: KEY CONFERENCES & EVENTS, 2024-2025
  • TABLE 17 LONG-READ SEQUENCING MARKET: IMPACT OF PORTER'S FIVE FORCES
  • TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)
  • TABLE 19 KEY BUYING CRITERIA, BY END USER
  • TABLE 20 LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 21 LONG-READ SEQUENCING CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 22 NORTH AMERICA: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 23 EUROPE: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 24 ASIA PACIFIC: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 25 LATIN AMERICA: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 26 MIDDLE EAST: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 GCC COUNTRIES: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 LONG-READ SEQUENCING INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 29 NORTH AMERICA: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 EUROPE: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 LATIN AMERICA: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 MIDDLE EAST: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 GCC COUNTRIES: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 LONG-READ SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 NORTH AMERICA: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 EUROPE: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 ASIA PACIFIC: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 LATIN AMERICA: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 MIDDLE EAST: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 GCC COUNTRIES: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 43 LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 EUROPE: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 48 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 EUROPE: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 53 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 55 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 EUROPE: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 62 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 65 LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 66 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 67 EUROPE: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 69 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 73 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 74 EUROPE: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 76 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 81 EUROPE: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 83 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 87 LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 EUROPE: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 90 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 91 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 92 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 93 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 95 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 EUROPE: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 98 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 99 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 100 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 LONG-READ SEQUENCING MARKET FOR METAGENOMICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 102 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR METAGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 103 EUROPE: LONG-READ SEQUENCING MARKET FOR METAGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR METAGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 105 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR METAGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR METAGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 107 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR METAGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 108 LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 109 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 110 EUROPE: LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 112 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 113 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 114 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 115 LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 117 EUROPE: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 118 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 119 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 120 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 121 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 122 LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 124 EUROPE: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 126 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 127 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 128 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 129 LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 130 LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 131 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 EUROPE: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 133 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 134 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 135 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 136 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 137 LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 138 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 139 EUROPE: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 141 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 142 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 143 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 144 LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 145 LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 146 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 EUROPE: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 149 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 150 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 151 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 152 LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 153 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 EUROPE: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 155 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 156 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 157 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 158 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 159 LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 160 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 EUROPE: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 162 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 163 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 164 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 165 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 166 LONG-READ SEQUENCING MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 167 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 168 EUROPE: LONG-READ SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 170 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 171 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 LONG-READ SEQUENCING MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 174 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 175 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 176 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 177 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 178 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 179 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 180 NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 181 US: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 182 US: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 183 US: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 184 US: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 185 US: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 186 US: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 187 CANADA: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 188 CANADA: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 189 CANADA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 190 CANADA: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 191 CANADA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 192 CANADA: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 193 EUROPE: LONG-READ SEQUENCING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 194 EUROPE: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 195 EUROPE: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 196 EUROPE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 197 EUROPE: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 198 EUROPE: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 199 EUROPE: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 200 GERMANY: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 201 GERMANY: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 202 GERMANY: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 203 GERMANY: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 204 GERMANY: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 205 GERMANY: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 206 UK: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 207 UK: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 208 UK: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 209 UK: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 210 UK: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 211 UK: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 212 FRANCE: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 213 FRANCE: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 214 FRANCE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 215 FRANCE: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 216 FRANCE: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 217 FRANCE: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 218 ITALY: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 219 ITALY: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 220 ITALY: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 221 ITALY: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 222 ITALY: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 223 ITALY: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 224 SPAIN: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 225 SPAIN: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 226 SPAIN: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 227 SPAIN: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 228 SPAIN: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 229 SPAIN: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 230 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 231 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 232 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 233 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 234 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 235 REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 236 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 237 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 238 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 239 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 240 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 241 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 242 ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 243 CHINA: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 244 CHINA: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 245 CHINA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 246 CHINA: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 247 CHINA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 248 CHINA: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 249 JAPAN: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 250 JAPAN: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 251 JAPAN: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 252 JAPAN: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 253 JAPAN: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 254 JAPAN: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 255 INDIA: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 256 INDIA: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 257 INDIA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 258 INDIA: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 259 INDIA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 260 INDIA: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 261 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 262 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 263 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 264 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 265 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 266 SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 267 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 268 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 269 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 270 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 271 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 272 REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 273 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 274 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 275 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 276 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 277 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 278 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 279 LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 280 BRAZIL: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 281 BRAZIL: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 282 BRAZIL: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 283 BRAZIL: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 284 BRAZIL: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 285 BRAZIL: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 286 MEXICO: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 287 MEXICO: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 288 MEXICO: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 289 MEXICO: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 290 MEXICO: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 291 MEXICO: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 292 ARGENTINA: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 293 ARGENTINA: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 294 ARGENTINA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 295 ARGENTINA: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 296 ARGENTINA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 297 ARGENTINA: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 298 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 299 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 300 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 301 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 302 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 303 REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 304 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 305 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 306 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 307 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 308 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 309 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 310 MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 311 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 312 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 313 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 314 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 315 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 316 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 317 GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 318 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 319 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 320 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 321 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 322 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 323 SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 324 UAE: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 325 UAE: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 326 UAE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 327 UAE: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 328 UAE: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 329 UAE: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 330 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 331 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 332 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 333 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 334 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 335 REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 336 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 337 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 338 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 339 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 340 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 341 REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 342 AFRICA: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 343 AFRICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
  • TABLE 344 AFRICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 345 AFRICA: LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 346 AFRICA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022-2029 (USD MILLION)
  • TABLE 347 AFRICA: LONG-READ SEQUENCING MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 348 OVERVIEW OF STRATEGIES ADOPTED BY KEY LONG-READ SEQUENCING COMPANIES
  • TABLE 349 LONG-READ SEQUENCING MARKET: DEGREE OF COMPETITION
  • TABLE 350 LONG-READ SEQUENCING MARKET: REGION FOOTPRINT
  • TABLE 351 LONG-READ SEQUENCING MARKET: OFFERING FOOTPRINT
  • TABLE 352 LONG-READ SEQUENCING MARKET: APPLICATION FOOTPRINT
  • TABLE 353 LONG-READ SEQUENCING MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 354 LONG-READ SEQUENCING MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 355 LONG-READ SEQUENCING MARKET: COMPANY FOOTPRINT (STARTUPS/SMES)
  • TABLE 356 LONG-READ SEQUENCING MARKET: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 357 LONG-READ SEQUENCING MARKET: EXPANSIONS, JANUARY 2021-JUNE 2024
  • TABLE 358 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW
  • TABLE 359 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS & SERVICES OFFERED
  • TABLE 360 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 361 PACBIO: COMPANY OVERVIEW
  • TABLE 362 PACBIO: PRODUCTS & SERVICES OFFERED
  • TABLE 363 PACBIO: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-JUNE 2024
  • TABLE 364 PACBIO: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 365 PACBIO: EXPANSIONS, JANUARY 2021-JUNE 2024
  • TABLE 366 PACBIO: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2024
  • TABLE 367 ILLUMINA, INC.: COMPANY OVERVIEW
  • TABLE 368 ILLUMINA, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 369 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024
  • TABLE 370 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 371 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 372 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 373 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 374 10X GENOMICS, INC.: COMPANY OVERVIEW
  • TABLE 375 10X GENOMICS, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 376 10X GENOMICS, INC.: PRODUCT LAUNCHES, JANUARY 2021-JUNE 2024
  • TABLE 377 QIAGEN: COMPANY OVERVIEW
  • TABLE 378 QIAGEN: PRODUCTS & SERVICES OFFERED
  • TABLE 379 QIAGEN: EXPANSIONS, JANUARY 2021-JUNE 2024
  • TABLE 380 BGI GROUP: COMPANY OVERVIEW
  • TABLE 381 BGI GROUP: PRODUCTS & SERVICES OFFERED
  • TABLE 382 AZENTA US, INC.: COMPANY OVERVIEW
  • TABLE 383 AZENTA US, INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 384 AZENTA US, INC.: EXPANSIONS, JANUARY 2021-JUNE 2024
  • TABLE 385 TAKARA BIO INC.: COMPANY OVERVIEW
  • TABLE 386 TAKARA BIO INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 387 TAKARA BIO INC.: DEALS, JANUARY 2021-JUNE 2024
  • TABLE 388 NOVOGENE CO., LTD.: COMPANY OVERVIEW
  • TABLE 389 NOVOGENE CO., LTD.: PRODUCTS & SERVICES OFFERED
  • TABLE 390 NOVOGENE CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2021-JUNE 2024
  • TABLE 391 REVVITY, INC.: COMPANY OVERVIEW
  • TABLE 392 REVVITY INC.: PRODUCTS & SERVICES OFFERED
  • TABLE 393 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 394 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
  • TABLE 395 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
  • TABLE 396 NEW ENGLAND BIOLABS: PRODUCTS & SERVICES OFFERED
  • TABLE 397 BASE CLEAR BV: COMPANY OVERVIEW
  • TABLE 398 BASE CLEAR BV: PRODUCTS & SERVICES OFFERED

List of Figures

  • FIGURE 1 LONG-READ SEQUENCING MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 LONG-READ SEQUENCING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 4 LONG-READ SEQUENCING MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2023
  • FIGURE 5 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023
  • FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF AGILENT TECHNOLOGIES, INC.
  • FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 LONG-READ SEQUENCING MARKET: CAGR PROJECTIONS
  • FIGURE 10 DATA TRIANGULATION
  • FIGURE 11 LONG-READ SEQUENCING MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 LONG-READ SEQUENCING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 LONG-READ SEQUENCING MARKET, BY USAGE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 LONG-READ SEQUENCING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 LONG-READ SEQUENCING MARKET: REGIONAL SNAPSHOT
  • FIGURE 18 GROWING TREND OF PERSONALIZED MEDICINES AND GENOMICS RESEARCH TO DRIVE MARKET
  • FIGURE 19 CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC LONG-READ SEQUENCING MARKET IN 2023
  • FIGURE 20 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 21 ACADEMIC & RESEARCH INSTITUTES SEGMENT DOMINATED MARKET IN 2023
  • FIGURE 22 LONG-READ SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN LONG-READ SEQUENCING MARKET
  • FIGURE 24 LONG-READ SEQUENCING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT, 2021-2023 (USD)
  • FIGURE 26 AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE, 2021-2023 (USD)
  • FIGURE 27 AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE, 2023 (USD)
  • FIGURE 28 INDICATIVE PRICE TREND OF INSTRUMENTS, BY REGION, 2021-2023 (USD)
  • FIGURE 29 PATENT ANALYSIS, 2014-2024
  • FIGURE 30 LONG-READ SEQUENCING MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 31 LONG-READ SEQUENCING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 32 LONG-READ SEQUENCING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING
  • FIGURE 34 KEY BUYING CRITERIA, BY END USER
  • FIGURE 35 RESEARCH FUNDING BY VARIOUS INSTITUTES/CENTERS, 2020-2024 (USD MILLION)
  • FIGURE 36 LONG-READ SEQUENCING INSTRUMENTS MARKET, BY VOLUME (2022-2029)
  • FIGURE 37 NORTH AMERICA: LONG-READ SEQUENCING MARKET SNAPSHOT
  • FIGURE 38 ASIA PACIFIC: LONG-READ SEQUENCING MARKET SNAPSHOT
  • FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN LONG-READ SEQUENCING MARKET, 2019-2023 (USD MILLION)
  • FIGURE 40 LONG-READ SEQUENCING MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
  • FIGURE 41 LONG-READ SEQUENCING INSTRUMENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
  • FIGURE 42 LONG-READ SEQUENCING CONSUMABLES MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
  • FIGURE 43 LONG-READ SEQUENCING SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
  • FIGURE 44 LONG-READ SEQUENCING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 45 LONG-READ SEQUENCING MARKET: COMPANY FOOTPRINT
  • FIGURE 46 LONG-READ SEQUENCING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 47 EV/EBITDA OF KEY VENDORS
  • FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 49 LONG-READ SEQUENCING MARKET: BRAND/SERVICE COMPARATIVE ANALYSIS
  • FIGURE 50 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2023)
  • FIGURE 51 PACBIO: COMPANY SNAPSHOT (2023)
  • FIGURE 52 ILLUMINA, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 53 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 55 10X GENOMICS, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 56 QIAGEN: COMPANY SNAPSHOT (2023)
  • FIGURE 57 AZENTA US, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 58 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 59 REVVITY, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 60 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)